XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated other Comprehensive loss
Statutory reserves
Beginning balance (in shares) at Dec. 31, 2023   315,006,942        
Beginning balance at Dec. 31, 2023 $ 564,190 $ 32 $ 1,481,241 $ (897,501) $ (25,614) $ 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss)/profit (113,134)     (113,134)    
Issuance of common stock in connection with vesting of share-based awards (in shares)   7,120,856        
Issuance of common stock in connection with vesting of share-based awards 0 $ 1 (1)      
Share-based compensation 30,391   30,391      
Issuance of warrants 779   779      
Foreign currency translation adjustments 3,862       3,862  
Ending balance (in shares) at Sep. 30, 2024   322,127,798        
Ending balance at Sep. 30, 2024 486,088 $ 33 1,512,410 (1,010,635) (21,752) 6,032
Beginning balance (in shares) at Jun. 30, 2024   315,510,447        
Beginning balance at Jun. 30, 2024 454,988 $ 32 1,506,031 (1,023,882) (33,225) 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss)/profit 13,247     13,247    
Issuance of common stock in connection with vesting of share-based awards (in shares)   6,617,351        
Issuance of common stock in connection with vesting of share-based awards 0 $ 1 (1)      
Share-based compensation 6,380   6,380      
Foreign currency translation adjustments 11,473       11,473  
Ending balance (in shares) at Sep. 30, 2024   322,127,798        
Ending balance at Sep. 30, 2024 $ 486,088 $ 33 1,512,410 (1,010,635) (21,752) 6,032
Beginning balance (in shares) at Dec. 31, 2024 323,144,134 323,144,134        
Beginning balance at Dec. 31, 2024 $ 387,895 $ 33 1,512,982 (1,092,958) (38,194) 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss)/profit (45,757)     (45,757)    
Issuance of common stock in connection with vesting of share-based awards (in shares)   622,095        
Share-based compensation 2,303   2,303      
Foreign currency translation adjustments $ 13,671       13,671  
Ending balance (in shares) at Sep. 30, 2025 323,766,229 323,766,229        
Ending balance at Sep. 30, 2025 $ 358,112 $ 33 1,515,285 (1,138,715) (24,523) 6,032
Beginning balance (in shares) at Jun. 30, 2025   323,666,611        
Beginning balance at Jun. 30, 2025 356,130 $ 33 1,514,531 (1,137,226) (27,240) 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss)/profit (1,489)     (1,489)    
Issuance of common stock in connection with vesting of share-based awards (in shares)   99,618        
Share-based compensation 754   754      
Foreign currency translation adjustments $ 2,717       2,717  
Ending balance (in shares) at Sep. 30, 2025 323,766,229 323,766,229        
Ending balance at Sep. 30, 2025 $ 358,112 $ 33 $ 1,515,285 $ (1,138,715) $ (24,523) $ 6,032